Increases Allergan, Inc.(NYSE:AGN) Price With Target To $140.00, By Citigroup Inc.

1467

Dallas, Texas 04/03/2014 (FINANCIALSTRENDS) –  Research examiners at Citigroup Inc. lifted their value focus on shares of Allergan, Inc.(NYSE:AGN) from $130.00 to $140.00 in a report discharged on Friday. The firm presently has a “purchase” rating on the stock. Citigroup Inc. Target value might show a potential upside of 12.81% from the organization’s current cost.

Experts comment on the stock

A few different experts have likewise as of late remarked on the stock. Examiners at Barclays raised their value focus on shares of Allergan Inc. (NYSE:AGN) from $95.00 to $130.00 in an examination note on March. They now have an “equivalent weight” rating on the stock. Independently, experts at BMO Capital Markets raised their value focus on shares of Allergan from $128.00 to $140.00 in an examination note on Tuesday, February 25th. At long last, examiners at Jpmorgan Chase & Co. raised their value focus on shares of Allergan Inc. (NYSE:AGN) from $115.00 to $130.00 in an exploration note on Wednesday, February twelfth. Six financing experts have appraised the stock with a hold rating and fourteen have purchase.

Allergan Inc. (NYSE:AGN) exchanged down 0.38% throughout mid-day exchanging on Friday, hitting $123.63. 1,764,027 shares of the organization’s stock exchanged hands. Allergan has a 1-year low of $81.33 and a 1-year high of $132.04. The stock’s 50-day moving normal is $126.2 and its 200-day moving normal is $106.7. The organization has a business top of $36.899 billion and a cost to-income degree of 38.07.

Profit report announced

Allergan Inc. (NYSE:AGN) last discharged its profit information on Tuesday, February fourth. The organization reported $1.12 income for every offer for the quarter, missing the experts’ agreement evaluation of $1.34 by $0.22. The organization had income of $1.66 million for the quarter, contrasted with the agreement appraisal of $1.65 million. Throughout the same quarter a year ago, the organization posted $1.15 income for every offer. Allergan’s income was up 14.4% contrasted with the same quarter a year ago. Experts want that Allergan Inc. (NYSE:AGN) will post $5.47 EPS for the current financial year.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.